Free Trial

Citius Pharmaceuticals (CTXR) Short Interest Ratio & Short Volume

Citius Pharmaceuticals logo
$1.28 -0.02 (-1.54%)
Closing price 04:00 PM Eastern
Extended Trading
$1.28 0.00 (0.00%)
As of 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Citius Pharmaceuticals Short Interest Data

Citius Pharmaceuticals (CTXR) has a short interest of 1.12 million shares, representing 10.64% of the float (the number of shares available for trading by the public). This marks a 15.50% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 1.22 million shares to cover all short positions.

Current Short Interest
1,120,000 shares
Previous Short Interest
969,700 shares
Change Vs. Previous Month
+15.50%
Dollar Volume Sold Short
$1.83 million
Short Interest Ratio
0.4 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
10,634,000 shares
Float Size
10,530,000 shares
Short Percent of Float
10.64%
Today's Trading Volume
226,538 shares
Average Trading Volume
1,220,332 shares
Today's Volume Vs. Average
19%
Short Selling Citius Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Citius Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CTXR Short Interest Over Time

CTXR Days to Cover Over Time

CTXR Percentage of Float Shorted Over Time

Citius Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20251,120,000 shares $1.83 million +15.5%10.6%0.4 $1.63
6/30/2025969,700 shares $1.54 million -28.2%9.2%0.4 $1.59
6/15/20251,350,000 shares $1.18 million +103.1%12.8%0.6 $0.87
5/31/2025664,600 shares $459.50 thousand +10.1%6.9%0.3 $0.69
5/15/2025603,400 shares $499.55 thousand -10.0%6.2%2.1 $0.83
4/30/2025670,600 shares $513.01 thousand -11.3%7.2%2.2 $0.77
4/15/2025755,900 shares $755.90 thousand +11.0%8.6%2.6 $1.00
3/31/2025681,200 shares $1.01 million +31.6%7.7%2.3 $1.49
3/15/2025517,600 shares $776.40 thousand -5.4%6.4%3.7 $1.50
2/28/2025547,000 shares $902.55 thousand +1.3%6.8%3.6 $1.65
2/15/2025540,100 shares $1.45 million +5.1%6.7%1.8 $2.69
1/31/2025513,900 shares $1.38 million -12.5%6.4%1.8 $2.69
1/15/2025587,000 shares $2.00 million -1.4%7.3%2.2 $3.40
12/31/2024595,300 shares $2.38 million +13.6%7.5%2.3 $4.00
12/15/2024523,900 shares $1.46 million -13.2%7.3%2.3 $2.79
11/30/2024603,700 shares $2.00 million +12.2%8.4%2.8 $3.32
11/15/2024537,900 shares $2.69 million -95.4%7.5%2.8 $5.00
10/31/202411,790,000 shares $4.39 million -5.1%N/A10.5 $0.37
10/15/202412,420,000 shares $4.65 million -2.7%N/A8.9 $0.37
9/30/202412,770,000 shares $6.39 million +1.9%N/A7.2 $0.50
9/15/202412,530,000 shares $6.51 million -6.4%N/A5.8 $0.52
8/31/202413,390,000 shares $7.63 million +9.0%N/A6.3 $0.57
8/15/202412,280,000 shares $7.20 million -16.1%N/A5.5 $0.59
7/31/202414,630,000 shares $13.24 million +21.9%N/A5.8 $0.91
7/15/202412,000,000 shares $9.18 million -15.2%N/A5.4 $0.77
6/30/202414,150,000 shares $8.26 million -8.5%N/A7.1 $0.58
6/15/202415,460,000 shares $9.67 million -2.8%N/A9.9 $0.63
5/31/202415,910,000 shares $11.10 million +9.9%N/A10.6 $0.70
5/15/202414,480,000 shares $9.05 million +0.4%N/A10.5 $0.62
4/30/202414,430,000 shares $10.77 million +9.4%N/A15.6 $0.75
4/15/202413,190,000 shares $10.09 million +6.1%N/A15.5 $0.77
3/31/202412,430,000 shares $11.15 million +2.1%N/A16.9 $0.90
3/15/202412,180,000 shares $8.97 million +2.7%N/A18.6 $0.74
2/29/202411,860,000 shares $9.11 million +2.4%N/A18.9 $0.77
2/15/202411,580,000 shares $9.75 million -0.3%N/A18.5 $0.84
1/31/202411,610,000 shares $7.21 million -16.7%N/A20.2 $0.62
1/15/202413,940,000 shares $10.46 million -4.7%N/A23.6 $0.75
12/31/202314,620,000 shares $11.06 million +8.6%N/A26.2 $0.76
12/15/202313,460,000 shares $10.73 million -15.0%N/A25.1 $0.80
11/30/202315,830,000 shares $12.20 million -1.3%N/A25.1 $0.77
Washington Thinks They Own Your Bank Account (Ad)

What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.

Get your free guide now by clicking here >>
11/15/202316,030,000 shares $12.31 million -5.1%N/A25.1 $0.77
10/31/202316,890,000 shares $12.71 million -1.9%N/A23.3 $0.75
10/15/202317,210,000 shares $12.00 million -7.2%N/A17.3 $0.70
9/30/202318,540,000 shares $12.69 million -4.5%N/A18 $0.68
9/15/202319,420,000 shares $14.74 million -1.1%N/A15.9 $0.76
8/31/202319,640,000 shares $17.92 million -1.1%N/A13.3 $0.91
8/15/202319,850,000 shares $17.10 million -4.6%N/A12.7 $0.86
7/31/202320,800,000 shares $20.59 million +2.0%N/A10.8 $0.99
7/15/202320,390,000 shares $24.26 million +8.7%N/A11 $1.19
6/30/202318,760,000 shares $22.51 million +27.9%N/A9.9 $1.20
6/15/202314,670,000 shares $18.48 million +6.6%N/A8.2 $1.26
5/31/202313,760,000 shares $15.96 million +13.4%N/A9.5 $1.16
5/15/202312,130,000 shares $15.53 million -10.8%N/A8.9 $1.28
4/30/202313,600,000 shares $19.72 million +6.7%N/A14.3 $1.45
4/15/202312,750,000 shares $20.91 million +6.5%9.5%14 $1.64
3/31/202311,970,000 shares $14.00 million +4.5%8.9%13.5 $1.17
3/15/202311,450,000 shares $11.79 million +1.5%8.6%13.1 $1.03
2/28/202311,280,000 shares $12.97 million +2.8%8.4%13.6 $1.15
2/15/202310,970,000 shares $13.49 million -5.4%8.2%13.5 $1.23
1/31/202311,600,000 shares $16.12 million +6.6%8.7%14.9 $1.39
1/15/202310,880,000 shares $12.19 million -0.7%8.1%15.3 $1.12
12/30/202210,960,000 shares $8.66 million -3.4%8.2%22 $0.79
12/15/202211,340,000 shares $12.81 million -0.4%N/A23.1 $1.13
11/30/202211,390,000 shares $13.33 million +4.5%N/A23.2 $1.17
11/15/202210,900,000 shares $11.66 million +1.3%N/A22.2 $1.07
10/31/202210,760,000 shares $11.62 million -3.0%N/A19.2 $1.08
10/15/202211,090,000 shares $11.98 million -0.1%N/A19.5 $1.08
9/30/202211,100,000 shares $13.43 million +6.3%N/A17.8 $1.21
9/15/202210,440,000 shares $12.84 million +3.6%N/A12.7 $1.23
8/31/202210,080,000 shares $12.40 million +2.0%N/A11.1 $1.23
8/15/20229,880,000 shares $12.55 million -0.7%N/A9.1 $1.27
7/31/20229,950,000 shares $8.89 million -4.8%N/A7.8 $0.89
7/15/202210,450,000 shares $9.54 million +1.1%N/A6.6 $0.91
6/30/202210,340,000 shares $9.51 million -29.1%N/A5.2 $0.92
6/15/202214,590,000 shares $13.92 million -2.7%N/A7.1 $0.95
5/31/202214,990,000 shares $14.09 million +7.2%11.2%7.9 $0.94
5/15/202213,990,000 shares $12.52 million +5.7%10.5%7.6 $0.90
4/30/202213,230,000 shares $13.36 million +25.1%9.9%7.1 $1.01
4/15/202210,580,000 shares $16.40 million +13.6%7.9%6.3 $1.55
3/31/20229,310,000 shares $16.66 million +2.4%7.0%6.2 $1.79
3/15/20229,090,000 shares $14.36 million +1.8%6.8%6.9 $1.58
2/28/20228,930,000 shares $13.75 million -11.2%6.7%6.2 $1.54
2/15/202210,060,000 shares $16.40 million -6.1%7.5%6.5 $1.63
1/31/202210,710,000 shares $16.17 million -5.3%8.0%6.7 $1.51
1/15/202211,310,000 shares $17.30 million -7.0%8.5%6.7 $1.53
12/31/202112,160,000 shares $18.73 million -7.3%9.1%6.6 $1.54
12/15/202113,110,000 shares $22.29 million +2.5%9.8%6.7 $1.70
11/30/202112,790,000 shares $21.62 million -5.0%9.6%6.2 $1.69
11/15/202113,460,000 shares $24.36 million -7.0%10.1%5.6 $1.81
10/29/202114,470,000 shares $27.06 million +2.1%10.8%5.9 $1.87
Washington Thinks They Own Your Bank Account (Ad)

What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.

Get your free guide now by clicking here >>
10/15/202114,170,000 shares $29.62 million -2.0%10.6%5.3 $2.09
9/30/202114,460,000 shares $29.35 million +0.4%10.8%4.9 $2.03
9/15/202114,410,000 shares $29.25 million +11.2%10.8%2.6 $2.03
8/31/202112,960,000 shares $29.16 million -5.4%9.8%1.6 $2.25
8/13/202113,700,000 shares $24.80 million -6.0%10.3%1.6 $1.81
7/30/202114,570,000 shares $27.54 million -13.9%11.8%1.7 $1.89
7/15/202116,920,000 shares $32.49 million -20.9%13.7%1.7 $1.92
6/30/202121,400,000 shares $74.47 million +40.4%17.4%2.1 $3.48
6/15/202115,240,000 shares $49.23 million -3.7%12.4%2 $3.23
5/28/202115,820,000 shares $36.07 million +8.6%12.9%2.5 $2.28
5/14/202114,570,000 shares $27.54 million +24.3%N/A1.7 $1.89
4/30/202111,720,000 shares $24.73 million -10.4%N/A0.8 $2.11
4/15/202113,080,000 shares $23.54 million +18.6%N/A0.9 $1.80
3/31/202111,030,000 shares $20.41 million +51.3%N/A0.8 $1.85
3/15/20217,290,000 shares $13.92 million -27.9%N/A0.6 $1.91
2/26/202110,110,000 shares $20.83 million +261.1%N/A0.9 $2.06
2/12/20212,800,000 shares $3.81 million +15.7%N/A0.3 $1.36
1/29/20212,420,000 shares $2.90 million +112.3%N/A1.6 $1.20
1/15/20211,140,000 shares $1.30 million -9.5%N/A1.4 $1.14
12/31/20201,260,000 shares $1.31 million -23.6%N/A1.8 $1.04
12/15/20201,650,000 shares $1.77 million +71.8%N/A2.2 $1.07
11/30/2020960,600 shares $947.82 thousand -20.0%N/A1.2 $0.99
11/15/20201,200,000 shares $1.15 million -9.1%N/A1.6 $0.95
10/30/20201,320,000 shares $1.33 million +6.5%N/A1.6 $1.01
10/15/20201,240,000 shares $1.33 million +53.3%N/A1.1 $1.07
9/30/2020809,100 shares $841.46 thousand +15.4%N/A0.6 $1.04
9/15/2020701,200 shares $743.27 thousand -8.9%N/A0.2 $1.06
8/31/2020769,400 shares $715.54 thousand +4.6%N/A0.3 $0.93
8/14/2020735,600 shares $787.09 thousand -59.8%N/A0.2 $1.07

CTXR Short Interest - Frequently Asked Questions

What is Citius Pharmaceuticals' current short interest?

Short interest is the volume of Citius Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 1,120,000 shares of CTXR short. 10.64% of Citius Pharmaceuticals' shares are currently sold short. Learn More on Citius Pharmaceuticals' current short interest.

What is a good short interest percentage for Citius Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.64% of Citius Pharmaceuticals' floating shares are currently sold short.

Is Citius Pharmaceuticals' short interest increasing or decreasing?

Citius Pharmaceuticals saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 1,120,000 shares, an increase of 15.5% from the previous total of 969,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Citius Pharmaceuticals' float size?

Citius Pharmaceuticals currently has issued a total of 10,630,000 shares. Some of Citius Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Citius Pharmaceuticals currently has a public float of 10,530,000 shares.

How does Citius Pharmaceuticals' short interest compare to its competitors?

10.64% of Citius Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Citius Pharmaceuticals: Werewolf Therapeutics, Inc. (3.14%), Precision BioSciences, Inc. (13.33%), Unicycive Therapeutics, Inc. (12.91%), ABVC BioPharma, Inc. (3.64%), PyroGenesis Canada Inc. (0.07%), PDS Biotechnology Corporation (5.34%), MiNK Therapeutics, Inc. (25.32%), CEL-SCI Co. (22.85%), vTv Therapeutics Inc. (0.98%), Exicure, Inc. (6.16%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short Citius Pharmaceuticals stock?

Short selling CTXR is an investing strategy that aims to generate trading profit from Citius Pharmaceuticals as its price is falling. CTXR shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Citius Pharmaceuticals?

A short squeeze for Citius Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CTXR, which in turn drives the price of the stock up even further.

How often is Citius Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTXR, twice per month. The most recent reporting period available is July, 15 2025.




This page (NASDAQ:CTXR) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners